Long-term immunosuppressive treatment is not associated with worse outcome in patients hospitalized in the intensive care unit for septic shock: the PACIFIC study
Julien Vaidie(Centre Hospitalier Universitaire de Limoges), Bruno François(Inserm), Thomas Daix, Bruno Evrard(Centre Hospitalier Universitaire de Clermont-Ferrand), Mathieu Lesouhaitier(Hôpital Pontchaillou), Edwige Péju(Centre National de la Recherche Scientifique), Antoine Guillon(Université de Tours), Xavier Wittebole(Cliniques Universitaires Saint-Luc), Philippe Vignon(Inserm), Louise-Marie Jandeaux(Hôpitaux Universitaires de Strasbourg), Jean-Claude Lachérade(Roche (France)), Pierre Asfar(Centre Hospitalier Universitaire d'Angers)
Cited by 10
Related Papers
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
The SOFA score—development, utility and challenges of accurate assessment in clinical trials
|Critical Care|2019|976
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894